Symbols

DRMA

Dermata Therapeutics·NASDAQ

--(--)

DRMA Filings

2026-03-26 · Key Events

Form 8-K - Current report

2026-03-26 · Financials

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

2026-03-17 · Ownership

Form 4 - Statement of changes in beneficial ownership of securities

2026-02-25 · Key Events

Form 8-K - Current report

2026-02-23 ·

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

2026-02-18 ·

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

2026-02-17 ·

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

2026-02-09 ·

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

2026-02-03 · Key Events

Form 8-K - Current report

2026-02-02 ·

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]